Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biopharmaceutical_drug
|
| gptkbp:activeIngredient |
gptkb:erythropoietin
|
| gptkbp:countryOfOrigin |
gptkb:Australia
|
| gptkbp:developedBy |
gptkb:AMRAD_Corporation
|
| gptkbp:hasTherapeuticUse |
treatment of anemia
|
| gptkbp:marketedIn |
gptkb:Australia
|
| gptkbp:relatedTo |
biotechnology industry
recombinant DNA technology |
| gptkbp:bfsParent |
gptkb:AMRAD
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
AMRAD EPO
|